The 2026/2027
Elite Test Bank:
Pharmacology for
Nurses (Adams 7th
Ed. Mastery)
PART 0: THE NAVIGATOR
● PART I: THE PRIMER (Critical 2026 Redlines & Professional Syntax)
● PART II: THE ELITE TEST BANK
○ Questions 1–15: Foundational Syntax & Application: Autonomic control,
pharmacokinetics, and 2026 regulatory redlines.
○ Questions 16–40: Professional Simulation: Mid-acuity clinical judgment,
integrating AHA PREVENT, ADA 2026 technology, and GOLD 2026 respiratory
standards.
○ Questions 41–66: Grandmaster Synthesis: High-stakes, multi-system cascading
failures requiring elite mechanistic intuition and toxicology mastery.
PART I: THE PRIMER
Mastering clinical pharmacology transcends memorizing drug classes; it requires synthesizing
the 2026 regulatory and pathophysiological landscapes into rapid, life-saving intuition. Relying
on outdated legacy algorithms guarantees clinical failure; bridging the gap between academic
theory and high-performance practice is the only path to elite competence.
The "Panic Button" Cheat Sheet (2026/2027 Redlines):
● AHA PREVENT: Stage 1 HTN (130-139/80-89) requires pharmacotherapy ONLY IF the
10-year PREVENT risk is ≥7.5%.
● ADA 2026: Automated Insulin Delivery (AID) and Continuous Glucose Monitoring (CGM)
are primary protocols at diagnosis. No C-peptide prerequisites exist.
● GOLD 2026: Ensifentrine (PDE3/4) added for maintenance; Dupilumab strictly for
, eosinophilic COPD (≥300 cells/μL).
● KDIGO 2026: Finerenone (ns-MRA) is foundational for T2D CKD (eGFR ≥25). Potassium
monitoring is non-negotiable.
● Joint Commission NPG #12: Nurse staffing is a high-stakes accreditation metric, directly
tied to validated patient acuity competencies, not mere headcount.
PART II: THE ELITE TEST BANK
Q1: A hospital faces an upcoming Joint Commission audit. Under the 2026 National
Performance Goal (NPG) #12, the nurse executive is evaluating the unit's medication
administration safety. Which metric is the MOST CRITICAL determinant of compliance for
staffing assignments related to high-risk infusions? A) The absolute ratio of registered nurses to
patients on the unit during the shift. B) Validated, documented staff competencies aligned
directly with patient acuity needs. C) The presence of a licensed practical nurse (LPN) to assist
with all intravenous verifications. D) The utilization of a computerized physician order entry
(CPOE) system for all biologic agents.
● The Answer: B (Validated, documented staff competencies aligned directly with patient
acuity needs.)
● Distractor Analysis:
○ A is incorrect: NPG #12 explicitly shifts the focus from simple headcounts (ratios) to
the specific skill mix and competency required for patient needs.
○ C is incorrect: LPNs cannot independently verify or manage high-risk infusions;
delegating this violates scope of practice.
○ D is incorrect: While CPOE is a safety standard, NPG #12 strictly regulates human
staffing competencies and nurse executive accountability, not IT infrastructure.
The Mentor's Analysis: The 2026 landscape eliminates the "warm body" approach to staffing.
NPG #12 demands that if you have a patient on a complex vasopressor titration, the nurse
assigned must possess validated, documented competency for that specific acuity.
Professional Intuition: Staffing is a clinical intervention, not a logistical suggestion.
Competency dictates the assignment.
Q2: A client with primary open-angle glaucoma is prescribed Pilocarpine ophthalmic drops.
Which systemic side effect should the practitioner FIRST assess for, indicating excessive
systemic absorption of this cholinergic agonist? A) Tachycardia and profound bronchodilation.
B) Extreme dry mouth and urinary retention. C) Bradycardia, diaphoresis, and excessive
salivation. D) Mydriasis and photophobia.
● The Answer: C (Bradycardia, diaphoresis, and excessive salivation.)
● Distractor Analysis:
○ A is incorrect: These are adrenergic (sympathetic) responses, not cholinergic.
○ B is incorrect: These are anticholinergic side effects (the opposite of Pilocarpine's
mechanism).
○ D is incorrect: Pilocarpine causes miosis (pupil constriction), not mydriasis
(dilation).
The Mentor's Analysis: Pilocarpine is a direct-acting cholinergic agonist. If it bypasses local
absorption and goes systemic, it triggers a massive parasympathetic "rest and digest" overdrive
(SLUDGE: Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis). Professional
Intuition: Cholinergics make everything wet and slow the heart down.
Q3: The 2026/2027 standard of care for a 55-year-old male presenting with Stage 1
Hypertension (135/85 mmHg) mandates the use of the AHA PREVENT calculator. The client
, has no history of CVD, but their PREVENT 10-year risk score is 8.2%. What is the BEST initial
intervention? A) Advise lifestyle modifications exclusively and recheck blood pressure in 6
months. B) Immediately initiate dual-therapy antihypertensives to prevent imminent target organ
damage. C) Initiate a single-agent antihypertensive therapy alongside aggressive lifestyle
modifications. D) Order an echocardiogram to determine if pharmacotherapy is truly warranted.
● The Answer: C (Initiate a single-agent antihypertensive therapy alongside aggressive
lifestyle modifications.)
● Distractor Analysis:
○ A is incorrect: Under the AHA 2025/2026 guidelines, a PREVENT score ≥7.5% in
Stage 1 HTN mandates the initiation of pharmacotherapy.
○ B is incorrect: Dual therapy is generally reserved for Stage 2 Hypertension
(≥140/90) or higher.
○ D is incorrect: The PREVENT calculator is the definitive trigger for treatment; an
echocardiogram is not a prerequisite for Step 1 therapy.
The Mentor's Analysis: The pooled cohort equations are obsolete. The PREVENT calculator is
the new elite standard. The operational threshold is 7.5%. Once a Stage 1 HTN patient crosses
that line, waiting for target organ damage is malpractice. Professional Intuition: Risk
calculations dictate the speed of intervention. ≥7.5% equals immediate pharmacological action.
Q4: A client with asthma is taking an inhaled corticosteroid (Beclomethasone) and a long-acting
beta-agonist (Salmeterol). Which statement by the client indicates a CRITICAL
misunderstanding of the pharmacodynamics of these agents? A) "I will rinse my mouth out with
water and spit after using the Beclomethasone inhaler." B) "If I wake up gasping for air, I will
take two puffs of the Salmeterol immediately." C) "I need to take both of these medications
every single day, even if I feel completely fine." D) "I will use a spacer with my inhalers to make
sure the medicine reaches my lungs."
● The Answer: B ("If I wake up gasping for air, I will take two puffs of the Salmeterol
immediately.")
● Distractor Analysis:
○ A is incorrect: This is correct behavior to prevent oral candidiasis.
○ C is incorrect: This is correct; these are maintenance drugs, not rescue agents.
○ D is incorrect: This is correct; a spacer enhances drug delivery.
The Mentor's Analysis: A LABA (Salmeterol) takes 10 to 20 minutes to onset. If a patient is
actively bronchospasming and uses a LABA instead of a SABA (Albuterol), they will suffocate
while waiting for the drug to work. Professional Intuition: Maintenance drugs do not save lives
in acute crises. Never confuse the shield with the sword.
Q5: You are administering Phenytoin intravenously to a client in status epilepticus. What is the
MOST IMPORTANT pharmacokinetic safety rule to adhere to during administration? A) Mix the
Phenytoin exclusively in Dextrose 5% in Water (D5W) to prevent rapid degradation. B)
Administer the infusion at a rate no faster than 50 mg/min and only in Normal Saline. C) Push
the medication as a rapid IV bolus to cross the blood-brain barrier immediately. D) Pre-medicate
the client with an antihistamine to prevent the expected allergic rash.
● The Answer: B (Administer the infusion at a rate no faster than 50 mg/min and only in
Normal Saline.)
● Distractor Analysis:
○ A is incorrect: Phenytoin rapidly precipitates (turns into crystals) in any
dextrose-containing solution.
○ C is incorrect: Pushing Phenytoin rapidly causes profound hypotension, severe
bradycardia, and cardiovascular collapse.
Elite Test Bank:
Pharmacology for
Nurses (Adams 7th
Ed. Mastery)
PART 0: THE NAVIGATOR
● PART I: THE PRIMER (Critical 2026 Redlines & Professional Syntax)
● PART II: THE ELITE TEST BANK
○ Questions 1–15: Foundational Syntax & Application: Autonomic control,
pharmacokinetics, and 2026 regulatory redlines.
○ Questions 16–40: Professional Simulation: Mid-acuity clinical judgment,
integrating AHA PREVENT, ADA 2026 technology, and GOLD 2026 respiratory
standards.
○ Questions 41–66: Grandmaster Synthesis: High-stakes, multi-system cascading
failures requiring elite mechanistic intuition and toxicology mastery.
PART I: THE PRIMER
Mastering clinical pharmacology transcends memorizing drug classes; it requires synthesizing
the 2026 regulatory and pathophysiological landscapes into rapid, life-saving intuition. Relying
on outdated legacy algorithms guarantees clinical failure; bridging the gap between academic
theory and high-performance practice is the only path to elite competence.
The "Panic Button" Cheat Sheet (2026/2027 Redlines):
● AHA PREVENT: Stage 1 HTN (130-139/80-89) requires pharmacotherapy ONLY IF the
10-year PREVENT risk is ≥7.5%.
● ADA 2026: Automated Insulin Delivery (AID) and Continuous Glucose Monitoring (CGM)
are primary protocols at diagnosis. No C-peptide prerequisites exist.
● GOLD 2026: Ensifentrine (PDE3/4) added for maintenance; Dupilumab strictly for
, eosinophilic COPD (≥300 cells/μL).
● KDIGO 2026: Finerenone (ns-MRA) is foundational for T2D CKD (eGFR ≥25). Potassium
monitoring is non-negotiable.
● Joint Commission NPG #12: Nurse staffing is a high-stakes accreditation metric, directly
tied to validated patient acuity competencies, not mere headcount.
PART II: THE ELITE TEST BANK
Q1: A hospital faces an upcoming Joint Commission audit. Under the 2026 National
Performance Goal (NPG) #12, the nurse executive is evaluating the unit's medication
administration safety. Which metric is the MOST CRITICAL determinant of compliance for
staffing assignments related to high-risk infusions? A) The absolute ratio of registered nurses to
patients on the unit during the shift. B) Validated, documented staff competencies aligned
directly with patient acuity needs. C) The presence of a licensed practical nurse (LPN) to assist
with all intravenous verifications. D) The utilization of a computerized physician order entry
(CPOE) system for all biologic agents.
● The Answer: B (Validated, documented staff competencies aligned directly with patient
acuity needs.)
● Distractor Analysis:
○ A is incorrect: NPG #12 explicitly shifts the focus from simple headcounts (ratios) to
the specific skill mix and competency required for patient needs.
○ C is incorrect: LPNs cannot independently verify or manage high-risk infusions;
delegating this violates scope of practice.
○ D is incorrect: While CPOE is a safety standard, NPG #12 strictly regulates human
staffing competencies and nurse executive accountability, not IT infrastructure.
The Mentor's Analysis: The 2026 landscape eliminates the "warm body" approach to staffing.
NPG #12 demands that if you have a patient on a complex vasopressor titration, the nurse
assigned must possess validated, documented competency for that specific acuity.
Professional Intuition: Staffing is a clinical intervention, not a logistical suggestion.
Competency dictates the assignment.
Q2: A client with primary open-angle glaucoma is prescribed Pilocarpine ophthalmic drops.
Which systemic side effect should the practitioner FIRST assess for, indicating excessive
systemic absorption of this cholinergic agonist? A) Tachycardia and profound bronchodilation.
B) Extreme dry mouth and urinary retention. C) Bradycardia, diaphoresis, and excessive
salivation. D) Mydriasis and photophobia.
● The Answer: C (Bradycardia, diaphoresis, and excessive salivation.)
● Distractor Analysis:
○ A is incorrect: These are adrenergic (sympathetic) responses, not cholinergic.
○ B is incorrect: These are anticholinergic side effects (the opposite of Pilocarpine's
mechanism).
○ D is incorrect: Pilocarpine causes miosis (pupil constriction), not mydriasis
(dilation).
The Mentor's Analysis: Pilocarpine is a direct-acting cholinergic agonist. If it bypasses local
absorption and goes systemic, it triggers a massive parasympathetic "rest and digest" overdrive
(SLUDGE: Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis). Professional
Intuition: Cholinergics make everything wet and slow the heart down.
Q3: The 2026/2027 standard of care for a 55-year-old male presenting with Stage 1
Hypertension (135/85 mmHg) mandates the use of the AHA PREVENT calculator. The client
, has no history of CVD, but their PREVENT 10-year risk score is 8.2%. What is the BEST initial
intervention? A) Advise lifestyle modifications exclusively and recheck blood pressure in 6
months. B) Immediately initiate dual-therapy antihypertensives to prevent imminent target organ
damage. C) Initiate a single-agent antihypertensive therapy alongside aggressive lifestyle
modifications. D) Order an echocardiogram to determine if pharmacotherapy is truly warranted.
● The Answer: C (Initiate a single-agent antihypertensive therapy alongside aggressive
lifestyle modifications.)
● Distractor Analysis:
○ A is incorrect: Under the AHA 2025/2026 guidelines, a PREVENT score ≥7.5% in
Stage 1 HTN mandates the initiation of pharmacotherapy.
○ B is incorrect: Dual therapy is generally reserved for Stage 2 Hypertension
(≥140/90) or higher.
○ D is incorrect: The PREVENT calculator is the definitive trigger for treatment; an
echocardiogram is not a prerequisite for Step 1 therapy.
The Mentor's Analysis: The pooled cohort equations are obsolete. The PREVENT calculator is
the new elite standard. The operational threshold is 7.5%. Once a Stage 1 HTN patient crosses
that line, waiting for target organ damage is malpractice. Professional Intuition: Risk
calculations dictate the speed of intervention. ≥7.5% equals immediate pharmacological action.
Q4: A client with asthma is taking an inhaled corticosteroid (Beclomethasone) and a long-acting
beta-agonist (Salmeterol). Which statement by the client indicates a CRITICAL
misunderstanding of the pharmacodynamics of these agents? A) "I will rinse my mouth out with
water and spit after using the Beclomethasone inhaler." B) "If I wake up gasping for air, I will
take two puffs of the Salmeterol immediately." C) "I need to take both of these medications
every single day, even if I feel completely fine." D) "I will use a spacer with my inhalers to make
sure the medicine reaches my lungs."
● The Answer: B ("If I wake up gasping for air, I will take two puffs of the Salmeterol
immediately.")
● Distractor Analysis:
○ A is incorrect: This is correct behavior to prevent oral candidiasis.
○ C is incorrect: This is correct; these are maintenance drugs, not rescue agents.
○ D is incorrect: This is correct; a spacer enhances drug delivery.
The Mentor's Analysis: A LABA (Salmeterol) takes 10 to 20 minutes to onset. If a patient is
actively bronchospasming and uses a LABA instead of a SABA (Albuterol), they will suffocate
while waiting for the drug to work. Professional Intuition: Maintenance drugs do not save lives
in acute crises. Never confuse the shield with the sword.
Q5: You are administering Phenytoin intravenously to a client in status epilepticus. What is the
MOST IMPORTANT pharmacokinetic safety rule to adhere to during administration? A) Mix the
Phenytoin exclusively in Dextrose 5% in Water (D5W) to prevent rapid degradation. B)
Administer the infusion at a rate no faster than 50 mg/min and only in Normal Saline. C) Push
the medication as a rapid IV bolus to cross the blood-brain barrier immediately. D) Pre-medicate
the client with an antihistamine to prevent the expected allergic rash.
● The Answer: B (Administer the infusion at a rate no faster than 50 mg/min and only in
Normal Saline.)
● Distractor Analysis:
○ A is incorrect: Phenytoin rapidly precipitates (turns into crystals) in any
dextrose-containing solution.
○ C is incorrect: Pushing Phenytoin rapidly causes profound hypotension, severe
bradycardia, and cardiovascular collapse.
